• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒性肝炎肝硬化相关门静脉高压患者经颈静脉肝内门体分流术(TIPS)置入预后评分的开发与验证:一项多中心回顾性研究

Development and validation of a prognostic score for TIPS placement in patients with viral hepatitis cirrhosis-related portal hypertension: a multi-center retrospective study.

作者信息

Que Zenglong, Wu Mingsong, Lai Shujie, Wang Lei, Mu Zhiyong, Yang Jinhui, Xiong Wei, Hu Hong, Liu Aimin, An Xuan, Yu Haodong, Cao Qin, Zhang Yanmei, Luo Wenwen, Wang Jun, Chen Dongfeng, Liu Fuquan, Zhang Dazhi, Wen Liangzhi

机构信息

Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.

Department of Infectious Diseases, The 960 Hospital of PLA, Jinan, China.

出版信息

Front Med (Lausanne). 2024 Sep 30;11:1456758. doi: 10.3389/fmed.2024.1456758. eCollection 2024.

DOI:10.3389/fmed.2024.1456758
PMID:39403285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11471721/
Abstract

INTRODUCTION

There is no established scoring model focused on viral hepatitis patients to predict the prognosis after transjugular intrahepatic portosystemic shunt (TIPS). We aimed to develop and validate a novel model based on the largest cohort for better prediction of both short-term (1 year) and long-term (3 years) postoperative prognoses after TIPS in viral hepatitis cirrhosis-related portal hypertension patients.

METHODS

A total of 925 viral hepatitis cirrhosis-related portal hypertension patients who underwent TIPS from nine hospitals were divided into the training and external validation cohorts. A novel Viral-associated Index of Post-TIPS score (VIPs) model was developed after performing Cox regression analysis. The VIPs model was compared to five previous models, namely, Child-Pugh, MELD, ALBI, CCG, and FIPS. Furthermore, X-tile software was used to stratify patients into low-, medium-, and high-risk groups.

RESULTS

The VIPs model included age, ascites, albumin, prothrombin time, total bilirubin, and sodium for post-TIPS prognosis prediction. The model demonstrated satisfying predictive efficiency in both discrimination and calibration, with an area under the curve of 0.781/0.774 (1 year/3 years) in the training cohort and 0.771/0.775 (1 year/3 years) in the external validation cohort, respectively.

DISCUSSION

We first developed and externally validated a novel VIPs model for better prediction of both short-term and long-term postoperative prognoses after TIPS in Chinese patients with viral hepatitis cirrhosis-related portal hypertension.

摘要

引言

目前尚无专门针对病毒性肝炎患者预测经颈静脉肝内门体分流术(TIPS)后预后的评分模型。我们旨在基于最大队列开发并验证一种新型模型,以更好地预测病毒性肝炎肝硬化相关门静脉高压患者TIPS术后的短期(1年)和长期(3年)预后。

方法

将来自9家医院的925例接受TIPS的病毒性肝炎肝硬化相关门静脉高压患者分为训练队列和外部验证队列。在进行Cox回归分析后开发了一种新型的TIPS术后病毒相关指数评分(VIPs)模型。将VIPs模型与之前的5种模型进行比较,即Child-Pugh、MELD、ALBI、CCG和FIPS。此外,使用X-tile软件将患者分为低、中、高风险组。

结果

VIPs模型纳入年龄、腹水、白蛋白、凝血酶原时间、总胆红素和钠用于预测TIPS术后预后。该模型在区分度和校准方面均显示出令人满意的预测效率,训练队列中曲线下面积分别为0.781/0.774(1年/3年),外部验证队列中为0.771/0.775(1年/3年)。

讨论

我们首次开发并在外部验证了一种新型VIPs模型,以更好地预测中国病毒性肝炎肝硬化相关门静脉高压患者TIPS术后的短期和长期预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/e314b65d9d0c/fmed-11-1456758-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/a25e56899ee7/fmed-11-1456758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/b984f8e0aaae/fmed-11-1456758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/6adfaabbfc6d/fmed-11-1456758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/5a9033afd511/fmed-11-1456758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/0e189ee35d8c/fmed-11-1456758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/743806740be7/fmed-11-1456758-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/d0b3d00b74c1/fmed-11-1456758-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/e314b65d9d0c/fmed-11-1456758-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/a25e56899ee7/fmed-11-1456758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/b984f8e0aaae/fmed-11-1456758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/6adfaabbfc6d/fmed-11-1456758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/5a9033afd511/fmed-11-1456758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/0e189ee35d8c/fmed-11-1456758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/743806740be7/fmed-11-1456758-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/d0b3d00b74c1/fmed-11-1456758-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/11471721/e314b65d9d0c/fmed-11-1456758-g008.jpg

相似文献

1
Development and validation of a prognostic score for TIPS placement in patients with viral hepatitis cirrhosis-related portal hypertension: a multi-center retrospective study.病毒性肝炎肝硬化相关门静脉高压患者经颈静脉肝内门体分流术(TIPS)置入预后评分的开发与验证:一项多中心回顾性研究
Front Med (Lausanne). 2024 Sep 30;11:1456758. doi: 10.3389/fmed.2024.1456758. eCollection 2024.
2
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.使用新型弗赖堡经颈静脉肝内门体分流术后生存指数优化经颈静脉肝内门体分流术后生存预测。
J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26.
3
Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.基于贝叶斯网络的门静脉高压症经颈静脉肝内门体分流术后患者生存预测模型
World J Gastroenterol. 2024 Apr 7;30(13):1859-1870. doi: 10.3748/wjg.v30.i13.1859.
4
Development of a new Cox model for predicting long-term survival in hepatitis cirrhosis patients underwent transjugular intrahepatic portosystemic shunts.一种用于预测接受经颈静脉肝内门体分流术的肝硬化患者长期生存的新Cox模型的开发。
World J Gastrointest Surg. 2024 Feb 27;16(2):491-502. doi: 10.4240/wjgs.v16.i2.491.
5
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.肝硬化腹水患者血清标志物与经颈静脉肝内门体分流术预后的相关性
World J Gastrointest Surg. 2024 Feb 27;16(2):481-490. doi: 10.4240/wjgs.v16.i2.481.
6
The Added Value of Sarcopenia on Existing Risk Scores to Predict Mortality after TIPS Placement: A Multicenter Study.肌肉减少症对 TIPS 放置后死亡率预测的现有风险评分的增值:一项多中心研究。
Acad Radiol. 2023 Sep;30 Suppl 1:S246-S256. doi: 10.1016/j.acra.2023.03.011. Epub 2023 Apr 5.
7
Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.白蛋白-胆红素及血小板-白蛋白-胆红素分级不能预测经颈静脉肝内门体分流术创建后的生存率。
Cardiovasc Intervent Radiol. 2018 Jul;41(7):1029-1034. doi: 10.1007/s00270-018-1923-2. Epub 2018 Mar 7.
8
A modified model for predicting mortality after transjugular intrahepatic portosystemic shunt: A multicentre study.经改良的经颈静脉肝内门体分流术术后死亡率预测模型:一项多中心研究。
Liver Int. 2024 Feb;44(2):472-482. doi: 10.1111/liv.15790. Epub 2023 Nov 27.
9
Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.经颈静脉肝内门体分流术治疗后病毒性肝炎相关肝硬化患者的长期临床结局。
Virol J. 2018 Oct 1;15(1):151. doi: 10.1186/s12985-018-1067-7.
10
Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.白蛋白-胆红素分级与 MELD 评分预测经颈静脉肝内门体分流术(TIPS)创建后的生存情况。
Diagn Interv Imaging. 2018 Mar;99(3):163-168. doi: 10.1016/j.diii.2017.10.008. Epub 2017 Nov 16.

本文引用的文献

1
A modified model for predicting mortality after transjugular intrahepatic portosystemic shunt: A multicentre study.经改良的经颈静脉肝内门体分流术术后死亡率预测模型:一项多中心研究。
Liver Int. 2024 Feb;44(2):472-482. doi: 10.1111/liv.15790. Epub 2023 Nov 27.
2
Comparative efficacy of early TIPS, Non-early TIPS, and Standard treatment in patients with cirrhosis and acute variceal bleeding: a network meta-analysis.早期 TIPS、非早期 TIPS 和标准治疗在肝硬化急性静脉曲张出血患者中的疗效比较:一项网状荟萃分析。
Int J Surg. 2024 Feb 1;110(2):1149-1158. doi: 10.1097/JS9.0000000000000865.
3
Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding.
用于识别肝硬化合并急性静脉曲张出血患者中抢先进行经颈静脉肝内门体分流术(TIPS)最佳候选者的预后评分的开发与验证
Hepatology. 2024 Jan 1;79(1):118-134. doi: 10.1097/HEP.0000000000000548. Epub 2023 Aug 18.
4
TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.TIPS 通过个体患者数据分析荟萃分析预防肝硬化和门静脉高压患者的进一步失代偿并改善生存。
J Hepatol. 2023 Sep;79(3):692-703. doi: 10.1016/j.jhep.2023.04.028. Epub 2023 May 2.
5
[Investigate of the etiology and prevention status of liver cirrhosis].[肝硬化的病因及防治现状调查]
Zhonghua Yi Xue Za Zhi. 2023 Mar 28;103(12):913-919. doi: 10.3760/cma.j.cn112137-20221017-02164.
6
Baveno VII - Renewing consensus in portal hypertension.《巴韦诺 VII 共识:门静脉高压领域的新共识》
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
7
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.使用新型弗赖堡经颈静脉肝内门体分流术后生存指数优化经颈静脉肝内门体分流术后生存预测。
J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26.
8
Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.七种非侵入性模型预测肝硬化失代偿和住院的比较。
Dig Dis Sci. 2021 Dec;66(12):4508-4517. doi: 10.1007/s10620-020-06763-9. Epub 2021 Jan 2.
9
Graphical calibration curves and the integrated calibration index (ICI) for survival models.生存模型的图形校准曲线和综合校准指数(ICI)
Stat Med. 2020 Sep 20;39(21):2714-2742. doi: 10.1002/sim.8570. Epub 2020 Jun 16.
10
Calculating the sample size required for developing a clinical prediction model.计算开发临床预测模型所需的样本量。
BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441.